Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Odimma
Odimma Therapeutics is a French biotech company specializing in personalized cancer immunotherapy. Their innovative platform, ODI-2001, utilizes synthetic DNA technology combined with adjuvants (MVA…
Odimma
Odimma Therapeutics is a French biotech company specializing in personalized cancer immunotherapy. Their innovative platform, ODI-2001, utilizes synthetic DNA technology combined with adjuvants (MVA…
TL;DR
Headquarters: Strasbourg / Illkirch-Graffenstaden, France
Lead programme: ODI-2001 personalised DNA-based immunotherapy
Founded: 2017
Tech focus: AI-driven neoantigen prediction + synthetic DNA vectors with MVA and anti-CTLA4 adjuvants
Known investors: Alsace Business Angels; Angels Santé; Capital Grand Est; Bpifrance
Company Overview
Problem Domain
Personalised cancer immunotherapy / precision oncology
Founded
2017
Industry
Biotechnology
Tech Stack
Funding Track Record
Public aggregator profiles list a single seed round with four investors.
Investor Signal
“Regional angel and public investors (Alsace Business Angels; Angels Santé; Capital Grand Est; Bpifrance)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week